A Living-Subject Cannabis Blood-Fraction Ratio Did Not Validate Postmortem Conversion

A plasma-to-whole-blood relationship observed in living cannabis users did not validate the same conversion after death. Giroud and colleagues found substantially greater variability in postmortem samples and cautioned against applying an exposure-time model in that setting.

The study compared different blood fractions

The investigators examined cannabinoid measurements in eight living regular cannabis users and six deceased people. The living comparison involved plasma and whole blood; the postmortem comparison involved the separated fraction described as serum and whole blood.

Among living subjects, ratios were more consistent within individuals, and the authors discussed an approximate factor of 1.6. Postmortem ratios were more scattered, with a reported mean around 2.4. These are study summaries, not exact conversion constants for an individual specimen.

Conversion and model validity are separate

Even if a blood-fraction ratio were estimated accurately, that would not establish that an exposure-time model remained valid in a different biological setting. Changing the input’s units or matrix does not recreate the conditions under which a model was developed.

The authors did not recommend applying the Huestis exposure-time model to postmortem specimens. Their caution should not be replaced by multiplying a whole-blood result by the postmortem group mean and treating the resulting estimate as validated.

Document the specimen before calculating

A case interpretation should identify whether the laboratory tested whole blood, plasma or serum, and whether the sample was collected before or after death. Those details belong alongside any concentration.

The study was small, and the observed variability limits precision. Its findings support careful specimen-specific interpretation; they do not establish a universal postmortem correction or convert cannabinoid exposure into proof of impairment at an earlier event.

Related: Why the blood fraction matters for THC interpretation.

Research cited

Giroud C; Menetrey A; Augsburger M; et al.; Forensic Science International; 2001. Delta-9-THC, 11-OH-Delta-9-THC and Delta-9-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Oral THCA-A Exposure Did Not Produce Detectable Hair THCA-A in One Volunteer

In a small controlled experiment, one volunteer took oral THCA-A repeatedly without producing detectable THCA-A in the sampled hair or sebum/sweat. That finding questions a simple assumption that systemic exposure necessarily yields a positive hair result for the same cannabinoid. This experiment tested the plant acid Moosmann and colleagues reported…

Spread the love

Read Article: Oral THCA-A Exposure Did Not Produce Detectable Hair THCA-A in One Volunteer

CB2 Effects on Established Neuropathy Did Not Establish Prevention of Its Onset

An experimental CB2 agonist could reduce hypersensitivity after neuropathy was established while only delaying its development under another treatment schedule. A mouse study illustrates why treatment of an existing response and prevention of its onset need separate evidence. The experiments asked different timing questions The supplied Guenther and colleagues preprint…

Spread the love

Read Article: CB2 Effects on Established Neuropathy Did Not Establish Prevention of Its Onset

A CB1 Modulator Changed Colonic Transit Without Changing Fecal Output

An experimental cannabinoid-receptor modulator reduced morphine-induced slowing of colonic transit without changing fecal boli production in the reported experiment. Those outcomes are related, but they are not interchangeable measures of gastrointestinal benefit. The compound was not cannabis The supplied Iyer and colleagues preprint examined GAT358, a negative allosteric modulator of…

Spread the love

Read Article: A CB1 Modulator Changed Colonic Transit Without Changing Fecal Output

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us